Sunday, February 1, 2015

Deals

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize

January 30, 2015 · Leave a Comment 

  JERSEY, Channel Islands, Jan. 29, 2015 (GLOBE NEWSWIRE) — Quotient Limited (“Quotient”) (Nasdaq:QTNT), a commercial-stage diagnostics company, and Ortho-Clinical Diagnostics, Inc., the global market leader in transfusion diagnostics, today announced that they are entering into a broad strategic collaboration to sell and distribute Quotient’s MosaiQ™ platform within the $2.8 billion global transfusion diagnostics market. Under the terms of an exclusive Distribution and Supply Agreement (“D&S Agreement”), Quotient retains all rights to commercialize... [Read the full story]

Deal News

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize

January 30, 2015 · Leave a Comment 

  JERSEY, Channel Islands, Jan. 29, 2015 (GLOBE NEWSWIRE) — Quotient Limited (“Quotient”) (Nasdaq:QTNT), a commercial-stage diagnostics company, and Ortho-Clinical Diagnostics, Inc., the global market leader in transfusion diagnostics, today announced that they are entering into a broad strategic collaboration to sell and distribute Quotient’s MosaiQ™ platform within the $2.8 billion global transfusion diagnostics market. Under the terms of an exclusive Distribution and Supply Agreement (“D&S Agreement”), Quotient retains all rights to commercialize... [Read the full story]

Legal

Tessera Technologies Reaches Global Settlement with Amkor

January 18, 2015 · Leave a Comment 

  SAN JOSE, Calif.–(BUSINESS WIRE)–Tessera Technologies, Inc. (NASDAQ:TSRA) (“Tessera” or the “Company”) today announced that its subsidiary, Tessera, Inc., has entered into an agreement with Amkor Technology, Inc. (“Amkor”) to settle all pending litigation between Amkor and Tessera, Inc. Under the terms of the agreement, Amkor will pay Tessera a total of $155 million, comprised of sixteen equal quarterly recurring payments commencing in the first quarter of 2015, and continuing through the fourth quarter of 2018. This settlement includes the... [Read the full story]

Bio

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize

January 30, 2015 · Leave a Comment 

  JERSEY, Channel Islands, Jan. 29, 2015 (GLOBE NEWSWIRE) — Quotient Limited (“Quotient”) (Nasdaq:QTNT), a commercial-stage diagnostics company, and Ortho-Clinical Diagnostics, Inc., the global market leader in transfusion diagnostics, today announced that they are entering into a broad strategic collaboration to sell and distribute Quotient’s MosaiQ™ platform within the $2.8 billion global transfusion diagnostics market. Under the terms of an exclusive Distribution and Supply Agreement (“D&S Agreement”), Quotient retains all rights to commercialize... [Read the full story]

University Tech Transfer

Cellectis and Ohio State University Enter Into Licensing Agreement

January 13, 2015 · Leave a Comment 

  Paris, January 13, 2015 – Cellectis SA (Alternext: ALCLS.PA) announces that it has entered into an exclusive license agreement with The Ohio State University, through the Ohio State Innovation Foundation, to develop and commercialize chimeric antigen receptor (CAR) technology targeting multiple myeloma cells. The CAR technology licensed to Cellectis is related to CS1, an antigen that is over-expressed in multiple myeloma cells. Cellectis intends to pursue the development of a CS1 CAR T-cell program for this targeted indication. Multiple myeloma is the second most common type... [Read the full story]

People

Boulder’s Innovation Center of the Rockies signs commercialization agreement with University of Wyoming

October 11, 2013 · Leave a Comment 

  The Innovation Center of the Rockies, a Boulder-based organization created to help research institutions commercialize technology, has entered into an agreement with the University of Wyoming, officials announced Tuesday. Financial terms of the agreement were not disclosed. The University of Wyoming is the first commercialization partner outside the state of Colorado for the nonprofit Innovation Center of the Rockies, which has inked similar deals with the University of Colorado, Colorado School of Mines, Colorado State University and the University of Denver. “I think that we’ve... [Read the full story]

Deals

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize

  JERSEY, Channel Islands, Jan. 29, 2015 (GLOBE NEWSWIRE) — Quotient Limited (“Quotient”) (Nasdaq:QTNT), a commercial-stage diagnostics company, and Ortho-Clinical Diagnostics, Inc., the global market leader in transfusion diagnostics, today announced that they are entering into a broad strategic collaboration to sell and distribute... Read more of this article


Astellas Pharma and Immunomic Therapeutics Announce Exclusive License

  HERSHEY, Pa., Rockville, Md. and TOKYO, Jan. 29, 2015 /PRNewswire/ – Immunomic Therapeutics, Inc. (“Immunomic Therapeutics“), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. (“Astellas”) today announced they have entered into an exclusive license agreement for... Read more of this article


Ukrainian Company Yunasko Reaches Licensing Agreement With Chinese Company

  KYIV, UKRAINE and HEBI, CHINA, January 2015. YUNASKO, a leader in research, development and manufacturing of ultracapacitor products, announce a licensing agreement with POWER TECH for the manufacturing and sales of high-performance ultracapacitors cells and ultracapacitor modules. YUNASKO and POWER TECH announced that they have entered into... Read more of this article


EaglePicher Licenses OneD Material’s SiNANOde™

  JOPLIN, Mo., Jan. 30, 2015 /PRNewswire/ — EaglePicher Technologies, LLC announced that it has entered into a License Agreement and an Engineering Services Agreement with OneD Material, to set up a new EaglePicher production facility in Joplin to produce SiNANOde™, a silicon-nanowire-based anode material for building lithium ion cells... Read more of this article


Contamac partners with Brien Holden

  Contamac Ltd., a leader in the development of specialist polymers and a major global provider of biocompatible materials for implantable and medical applications to the ophthalmic industry, and Brien Holden Vision Institute, whose mission is to develop new solutions for vision care and eliminate vision impairment and avoidable blindness, have... Read more of this article


Mile High Opthalmics and University of Colorado launch device to ease cataract surgery

  AURORA, Colo., January 26, 2015 – A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC. Cataracts, clouding of the lens inside the eye, are the most common cause of impaired vision worldwide. In the... Read more of this article


SK Telecom and Nokia Networks Announce World’s First Commercialization of eICIC

  Seoul, Korea – SK Telecom (NYSE:SKM) today announced that it, together with Nokia Networks, commercialized a core LTE-Advanced (LTE-A) technology called ‘Enhanced Inter-Cell Interference Coordination (eICIC)’ for the first time in the world. eICIC is a technology that controls signal interference between macro and micro base stations to... Read more of this article


HII Technologies Announces Exclusive Agreement and Commercialization of Hydropath Technology

  HOUSTON, TX–(Marketwired – January 28, 2015) – HII Technologies, Inc. (OTCQB: HIIT) (“HII Technologies” or the “Company”), an oilfield service company focused in frac water management headquartered in Houston, Texas, today announced an exclusive agreement with HydroFLOW® Holdings USA, LLC. Under... Read more of this article


iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

  LOS ANGELES, Jan. 28, 2015 /PRNewswire/ – iCura Vision and Columbia Technology Ventures announced today that iCura Vision has licensed the intellectual property portfolio and associated research and development program for a promising oral medication intended to slow or halt the progression of “dry” Age-Related Macular Degeneration... Read more of this article


Prime Focus inks technology licensing deal with Gener8

  VANCOUVER, BC, January 27, 2015 — Gener8 Media Corp. (CSE: GNR) (“Gener8” or the “Company”) is pleased to announce a licensing and 3D conversion partnership with the Prime Focus Group (“Prime Focus”). According to the terms of the definitive agreement (the “Transaction”), Prime Focus will enter into an exclusive worldwide license... Read more of this article


More Posts From Deals

Legal

Tessera Technologies Reaches Global Settlement with Amkor

  SAN JOSE, Calif.–(BUSINESS WIRE)–Tessera Technologies, Inc. (NASDAQ:TSRA)... 


Philips, Nintendo Resolve Patent Disputes; Reaches Patent License Agreement

  Koninklijke Philips Electronics NV (PHGFF.PK,PHG: Quote) said it has resolved... 


More Posts From Legal

University Tech Transfer

Cellectis and Ohio State University Enter Into Licensing Agreement

  Paris, January 13, 2015 – Cellectis SA (Alternext: ALCLS.PA) announces... 


Samsung Electronics inks licensing agreement with University of Michigan spinoff

  A University of Michigan-developed energy storage and controls company announced... 


More Posts From University Tech Transfer